Literature DB >> 8139487

Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.

L Ghizzoni1, S Bernasconi, R Virdis, A Vottero, M Ziveri, C Volta, L Iughetti, G Giovannelli.   

Abstract

To assess whether the quantitative and qualitative aspects of cortisol, 17-hydroxyprogesterone (17-OHP), and androstenedione (D4A) secretion in patients with nonclassic congenital adrenal hyperplasia (NCCAH) differ from those in normal children, 24-hour serum concentrations of these steroids were measured in five prepubertal patients with NCCAH and five normal prepubertal children. Adrenal steroid profiles obtained by 30-minute sampling were analyzed by the Pulsar program. In comparison to normal children, the 24-hour quantitative parameters of 17-OHP and D4A secretion were significantly greater in NCCAH patients, but serum cortisol concentrations were similar in the two groups. When daytime and nighttime hormone releases were separately analyzed, a significant nocturnal elevation of the cortisol area under the curve above zero level (AUCo) and 12-hour mean and 17-OHP AUCo, AUC above baseline, mean peak height, amplitude, area, and 12-hour mean was detected in normal subjects only. Conversely, NCCAH patients exhibited an increased frequency and number of 17-OHP secretory peaks at night together with a reduction of the interpeak interval. No significant day/night differences in D4A concentrations were detected either in normals or in the patients. In conclusion, the results of the present study indicate that patients with NCCAH have a distinct pattern of adrenal steroid secretion characterized by a high-frequency 17-OHP release accompanied by a relative nocturnal cortisol deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139487     DOI: 10.1016/0026-0495(94)90107-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.

Authors:  C Morán; E S Knochenhauer; R Azziz
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

2.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is associated with a prolonged gestational age.

Authors:  Jackie O'Sullivan; Sriram Iyer; Norman Taylor; Tim Cheetham
Journal:  Arch Dis Child       Date:  2007-04-20       Impact factor: 3.791

3.  11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase Deficiency.

Authors:  Smita Jha; Adina F Turcu; Ninet Sinaii; Brittany Brookner; Richard J Auchus; Deborah P Merke
Journal:  J Endocr Soc       Date:  2020-12-11

4.  Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Min Jae Kang; Shin Mi Kim; Young Ah Lee; Choong Ho Shin; Sei Won Yang
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

5.  Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.

Authors:  Deborah P Merke; Ashwini Mallappa; Wiebke Arlt; Aude Brac de la Perriere; Angelica Lindén Hirschberg; Anders Juul; John Newell-Price; Colin G Perry; Alessandro Prete; D Aled Rees; Nicole Reisch; Nike Stikkelbroeck; Philippe Touraine; Kerry Maltby; F Peter Treasure; John Porter; Richard J Ross
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

6.  An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia.

Authors:  Mahmoud Al-Kofahi; Mariam A Ahmed; Mutaz M Jaber; Thang N Tran; Brian A Willis; Cheryl L Zimmerman; Maria T Gonzalez-Bolanos; Richard C Brundage; Kyriakie Sarafoglou
Journal:  Br J Clin Pharmacol       Date:  2020-07-26       Impact factor: 3.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.